Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alliance Pharma ( (GB:APH) ) has issued an announcement.
Alliance Pharma plc has published its Annual Report & Accounts for the year ending 31 December 2024, which is now available on the company’s website. This publication reflects the company’s ongoing commitment to transparency and provides stakeholders with insights into its financial performance and strategic initiatives.
More about Alliance Pharma
Alliance Pharma plc is a growing consumer healthcare company focused on empowering individuals to improve their health and wellbeing through trusted and proven brands. The company achieves organic growth by investing in priority brands, innovation, and selective geographic expansion. Headquartered in the UK, Alliance Pharma operates across Europe, North America, and the Asia Pacific region, employing around 290 people and maintaining an asset-light model by outsourcing manufacturing and logistics.
YTD Price Performance: 40.33%
Average Trading Volume: 6,578,798
Technical Sentiment Signal: Strong Sell
Current Market Cap: £346.5M
Learn more about APH stock on TipRanks’ Stock Analysis page.